Chargement en cours...
Maximizing Opportunities and Avoiding Mistakes in Triple Therapy for Hepatitis C Virus
Recently developed drugs and innovative strategies for the treatment of chronic infection with genotype 1 hepatitis C virus (HCV) have become the standard of care. The protease inhibitors telaprevir (Incivek) and boceprevir (Victrelis) are the first direct-acting antiviral (DAA) agents approved, and...
Enregistré dans:
| Auteurs principaux: | , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
2012
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3683992/ https://ncbi.nlm.nih.gov/pubmed/22537438 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1053/j.gastro.2012.02.013 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|